Literature DB >> 23682843

Comment on basal cell carcinoma rebound after cessation of vismodegib in an individual with basal cell nevus syndrome.

Mina S Ally1, Ashley Wysong, Jean Y Tang, Sumaira Aasi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23682843     DOI： 10.1111/dsu.12250

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN： 1076-0512            Impact factor:   3.398


× No keyword cloud information.
  1 in total

Review 1.  Vismodegib hedgehog-signaling inhibition and treatment of basal cell carcinomas as well as keratocystic odontogenic tumors in Gorlin syndrome.

Authors:  Patrick Booms; Marc Harth; Robert Sader; Shahram Ghanaati
Journal:  Ann Maxillofac Surg       Date:  2015 Jan-Jun
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.